EyePoint Pharmaceuticals, Watertown, MA

EyePoint Pharmaceuticals

www.eyepointpharma.com

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.eyepointpharma.com
480 Pleasant Street Suite A-210
Watertown, MA USA 02472
Phone: 833.393.7646

Name	Title	Contact Details
John Weet	Senior Vice President of Regulatory Affairs and Quality	Profile
Isabelle Lefebvre	Chief Regulatory Officer	Profile
Ron Honig	Senior Vice President, General Counsel and Company Secretary	Profile

Similar Companies

Robert Half

Robert Half, the world`s first and largest specialized talent solutions firm, connects opportunities at great companies with highly skilled job seekers. We offer contract, temporary and permanent placement solutions for roles in finance and accounting, technology, marketing and creative, legal, and administrative and customer support. Named to Fortune`s World`s Most Admired Companies and 100 Best Companies to Work For® lists and a Forbes Best Employer for Diversity, Robert Half is the parent company of Protiviti®. Robert Half is traded on the New York Stock Exchange (symbol: RHI) and is a member of the S&P 500 index.

CLOs on the Move